Charles B Nguyen Christopher T Su Meredith Morgan Ajjai S Alva
10.3389/fonc.2022.1000023
Front Oncol
2022 Oct 6;12:1000023.
immune-related adverse events immunotherapy immunotherapy adverse reactions meibomian gland dysfunction ocular toxicity
CC BY
https://pubmed.ncbi.nlm.nih.gov/36276085/
Case Reports
PMC9582237
36276085
Case report: Immune-mediated meibomian gland dysfunction following pembrolizumab therapy for advanced urothelial carcinoma
2022